Secondary analysis of the WOMAN trial to explore the risk of sepsis after invasive treatments for postpartum hemorrhage.

To examine the association between the use of invasive treatments for postpartum hemorrhage and the risk of sepsis and severe sepsis. In this secondary data analysis, certain invasive treatments for postpartum hemorrhage appear to increase the risk of sepsis. Further research is needed to confirm this finding and investigate the role of prophylactic antibiotics during these procedures. The harms and benefits of such interventions must be carefully weighed, both in treatment guidelines and during individual patient management.

Source: Current Awareness Service for Health (CASH) - June 19, 2019 Category: Consumer Health News Source Type: news